Bicycle Therapeutics plc (50BA) — Cash Flow Reinvestment Rate
Latest as of June 2023:
0.02x
Bicycle Therapeutics plc (50BA) has a Cash Flow Reinvestment Rate of 0.02x as of June 2023, reinvesting €554.00K (capex €277.00K plus investments €-277.00K) from operating cash flow of €34.10 Million. See Bicycle Therapeutics plc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.02x
(Capex + Investments) / Operating CF
Total Reinvested
€554.00K
Capex + Investments
Operating Cash Flow
€34.10 Million
EUR
Capital Expenditures
€277.00K
EUR
Annual Cash Flow Reinvestment Rate for Bicycle Therapeutics plc (None–None)
Year-by-year capital reinvestment analysis for Bicycle Therapeutics plc. See Bicycle Therapeutics plc (50BA) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow